Literature DB >> 115049

The effect of cannabidiol, alone and in combination with ethanol, on human performance.

B E Belgrave, K D Bird, G B Chesher, D M Jackson, K E Lubbe, G A Starmer, R K Teo.   

Abstract

Fifteen volunteers received cannabidiol (CBD) (320 microgram/kg) or placebo (both orally, T0), and 60 min later they consumed an ethanolic beverage (0.54 g/kg) or placebo. The effects were measured at T1 (100 min after CBD ingestion), T2 (160 min) and T3 (220 min) using cognitive, perceptual and motor function tests. Factorial analysis indicated that test procedures could be adequately expressed by three rotated factors: A reaction speed factor (I), a standing steadiness factor (II) and a psychomotor coordination/cognitive factor (III). Ethanol produced a significant decrement in factor III. There was no demonstrable effect of CBD, either alone or in combination with ethanol. Neither CBD nor ethanol produced any significant effect on pulse rate. Prior administration of CBD did not significantly affect the blood ethanol levels. Whilst the subjects were able to identify correctly when they were given ethanol, they did not report any subjective effects of CBD.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115049     DOI: 10.1007/bf00496070

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.

Authors:  I G Karniol; I Shirakawa; N Kasinski; A Pfeferman; E A Carlini
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

2.  Cannabinoid content of some English reefers.

Authors:  J W Fairbairn; I Hindmarch; S Simic; E Tylden
Journal:  Nature       Date:  1974-05-17       Impact factor: 49.962

3.  Cannabidiol and cannabinol in man.

Authors:  L E Hollister
Journal:  Experientia       Date:  1973

4.  Pharmacology of orally administered 9 -tetrahydrocannabinol.

Authors:  M Perez-Reyes; M A Lipton; M C Timmons; M E Wall; D R Brine; K H Davis
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

5.  Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions.

Authors:  P J Welburn; G A Starmer; G B Chesher; D M Jackson
Journal:  Psychopharmacologia       Date:  1976

6.  The effect of (-) trans-delta9-tetrahydrocannabinol, alone and in combination with ethanol, on human performance.

Authors:  B E Belgrave; K D Bird; G B Chesher; D M Jackson; K E Lubbe; G A Starmer; R K Teo
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

7.  Ethanol and delta9-tetrahydrocannabinol interactive effects on human perceptual, cognitive and motor functions. II.

Authors:  G B Chesher; H M Franks; D M Jackson; G A Starmer; R K Teo
Journal:  Med J Aust       Date:  1977-04-02       Impact factor: 7.738

8.  The interaction of ethanol and delta9-tetrahydrocannabinol in man: effects on perceptual, cognitive and motor functions.

Authors:  G B Chesher; H M Franks; V R Hensley; W J Hensley; D M Jackson; G A Starmer; R K Teo
Journal:  Med J Aust       Date:  1976-07-31       Impact factor: 7.738

9.  Interaction of cannabis and general anaesthetic agents in mice.

Authors:  G B Chesher; D M Jackson; G A Starmer
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

10.  Anticonvulsant effects of cannabinoids in mice: drug interactions within cannabinoids and cannabinoid interactions with phenytoin.

Authors:  G B Chesher; D M Jackson
Journal:  Psychopharmacologia       Date:  1974-07-11
View more
  21 in total

1.  Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry.

Authors:  Krista Lisdahl Medina; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert
Journal:  Neurotoxicol Teratol       Date:  2006-12-12       Impact factor: 3.763

Review 2.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

3.  Investigating drug--ethanol interactions.

Authors:  G A Starmer; K D Bird
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

4.  Intercannabinoid and cannabinoid-ethanol interactions on human performance.

Authors:  K D Bird; T Boleyn; G B Chesher; D M Jackson; G A Starmer; R K Teo
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review.

Authors:  Jasmine Turna; Sabrina K Syan; Benicio N Frey; Brian Rush; Mary Jean Costello; Mark Weiss; James MacKillop
Journal:  Alcohol Clin Exp Res       Date:  2019-02-19       Impact factor: 3.455

6.  Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.

Authors:  Michael A Taffe; Kevin M Creehan; Sophia A Vandewater
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

7.  Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.

Authors:  Gregory I Liou
Journal:  World J Diabetes       Date:  2010-03-15

8.  Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.

Authors:  Erica J Carrier; John A Auchampach; Cecilia J Hillard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-03       Impact factor: 11.205

9.  Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes.

Authors:  A B El-Remessy; Y Khalifa; S Ola; A S Ibrahim; G I Liou
Journal:  Mol Vis       Date:  2010-08-04       Impact factor: 2.367

10.  Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.

Authors:  C A Hunt; R T Jones; R I Herning; J Bachman
Journal:  J Pharmacokinet Biopharm       Date:  1981-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.